Novel Biotechnology Platform Based Vaccine Manufacturing for Covid-19 and Beyond
This work presents a systematic review and analysis of the traditional vaccine manufacturing methods and the "novel" biotechnology platform based methods with a reference to the COVID-19 vaccine manufacturing scenarios.
Penn State Only
Files are only accessible to users logged-in with a Penn State Access ID.
|Novel Biotechnology Platform Based Vaccine Manufacturing for Covid-19 and Beyond
|In Copyright (Rights Reserved)
|June 28, 2021
This resource is currently not in any collection.